View:
Download DOC
Download PDF
Download XLS
SEC FORM 4 SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940 		 
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
1. Name and Address of Reporting Person*
EW HEALTHCARE PARTNERS FUND 2, L.P.
(Last) (First) (Middle)
21 WATERWAY AVENUE, SUITE 225
(Street)
THE WOODLANDS TX 77380
(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
TELA Bio, Inc. [ TELA ] 		5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director 10% Owner
Officer (give title below) X Other (specify below)
See Footnote 2
3. Date of Earliest Transaction (Month/Day/Year)
03/23/2021
4. If Amendment, Date of Original Filed (Month/Day/Year)
 6. Individual or Joint/Group Filing (Check Applicable Line)
Form filed by One Reporting Person
X Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock, par value $0.001 per share 03/23/2021 P 10,000 A $13.79 1,534,578 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 03/24/2021 P 2,660 A $13.94 1,537,238 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 03/25/2021 P 5,000 A $13.11 1,542,238 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 03/26/2021 P 37,851 A $12.88 1,580,089 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/08/2021 P 206 A $13.67 1,580,295 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/12/2021 P 2,893 A $13.57 1,583,188 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/19/2021 P 625 A $13.61 1,583,813 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/20/2021 P 4,678 A $13.54 1,588,491 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/21/2021 P 365 A $13.59 1,588,856 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/22/2021 P 5,000 A $13.54 1,593,856 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/23/2021 P 5,000 A $13.51 1,598,856 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/27/2021 P 15,000 A $13.49 1,613,856 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 04/28/2021 P 200 A $13.41 1,614,056 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 05/05/2021 P 7,500 A $13.28 1,621,556 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 05/06/2021 P 6,499 A $13.15 1,628,055 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 05/07/2021 P 7,500 A $13.15 1,635,555 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 05/10/2021 P 7,500 A $12.93 1,643,055 I See footnotes(1)(2)
Common Stock, par value $0.001 per share 05/11/2021 P 7,500 A $12.75 1,650,555 I See footnotes(1)(2)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
1. Name and Address of Reporting Person*
EW HEALTHCARE PARTNERS FUND 2, L.P.
(Last) (First) (Middle)
21 WATERWAY AVENUE, SUITE 225
(Street)
THE WOODLANDS TX 77380
(City) (State) (Zip)
1. Name and Address of Reporting Person*
EW HEALTHCARE PARTNERS FUND 2-A, L.P.
(Last) (First) (Middle)
21 WATERWAY AVENUE, SUITE 225
(Street)
THE WOODLANDS TX 77380
(City) (State) (Zip)
1. Name and Address of Reporting Person*
EW Healthcare Partners Fund 2 GP, L.P.
(Last) (First) (Middle)
21 WATERWAY AVENUE, SUITE 225
(Street)
THE WOODLANDS TX 77380
(City) (State) (Zip)
1. Name and Address of Reporting Person*
EW Healthcare Partners Fund 2-UGP, L.P.
(Last) (First) (Middle)
21 WATERWAY AVENUE, SUITE 225
(Street)
THE WOODLANDS TX 77380
(City) (State) (Zip)
Explanation of Responses:
1. Shares shown above were the aggregate amount of shares purchased by EW Healthcare Partners Fund 2, L.P. ("Fund 2") and EW Healthcare Partners Fund 2-A, L.P. ("Fund 2-A") on each date set forth above. Exhibit 99.1 attached hereto shows the breakdown by each Fund on each purchase date and the total shares beneficially owned by each Fund following each such purchase:
2. EW Healthcare Partners Fund 2 GP, L.P. (the "EW Funds GP"), is the general partner of each of EW Healthcare Partners Fund 2, L.P. ("Fund 2'") and EW Healthcare Partners Fund 2-A, L.P. (''EW Fund 2-A" and together with EW Fund 2, the ''EW Funds"). EW Healthcare Partners Fund 2- UGP, LLC (the "General Partner") is the general partner of EW Funds GP. The General Parmer holds sole voting and dispositive power over the shares held by each of the EW Funds (the "Shares''). The managers of the General Parmer are Martin P. Sutter, Ron Eastman, Scott Bany and Petri Vainio (collectively, the ''Managers'') and may exercise voting and investment control over the Shares only by majority action of the Managers. Each individual Manager, the EW Funds GP and the General Partner disclaims beneficial ownership over the Shares except to the extent of his or its respective pecuniary interest therein.
Remarks:
EW HEALTHCARE PARTNERS FUND 2, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 05/13/2021
EW HEALTHCARE PARTNERS FUND 2-A, L.P., By: EW Healthcare Partners Fund 2 GP, L.P., its General Partner, By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 05/13/2021
EW HEALTHCARE PARTNERS FUND 2 GP, L.P., By: EW Healthcare Partners Fund 2-UGP, LLC, its General Partner, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 05/13/2021
EW HEALTHCARE PARTNERS FUND 2-UGP, LLC, By: Martin P. Sutter, Attorney-in-Fact, /s/ Martin P. Sutter 05/13/2021
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
                           EXHIBIT  99.1  TO  FORM  4


EW HEALTHCARE PARTNERS FUND 2, L.P.:     EW HEALTHCARE PARTNERS FUND 2-A, L.P.:
------------------------------------     -------------------------------------

Transaction Date   Shares Acquired   Total Owned   Shares Acquired   Total Owned
----------------   ---------------   -----------   ---------------   -----------
3/23/2021               4066            624,209         5934           910,369
3/24/2021               1082            625 291         1578           911,947
3/25/2021               2033            627,324         2967           914,914
3/26/2021               15392           643,716         22459          937,373
4/8/2021                206             642,922           0            937,373
4/12/2021               1382            644,304         1511           938,884
4/19/2021               254             644,558          371           939,255
4/20/2021               1902            646,460         2776           942,031
4/21/2021               0               646,460         365            942,396
4/22/2021               2398            648,858         2602           944,998
4/23/2021               2033            650,891         2967           947,965
4/27/2021               6100            656,991         8900           956,865
4/28/2021               0               656,991         200            957,065
5/5/2021                3250            660,341         4250           961,315
5/6/2021                2643            662,884         3856           965,171
5/7/2021                3050            665,934         4450           969,621
5/10/2021               3050            668,984         4450           974,071
5/11/2021               3050            672,034         4450           978,521